Upgrade to SI Premium - Free Trial

Biogen completes acquisition of RayThera in immunology push

August 6, 2026 6:15 PM
Biogen Inc. (Nasdaq: BIIB) announced the completion of its acquisition of RayThera Inc., a privately held biotechnology company focused on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions